Exact Mass: 507.319586
Exact Mass Matches: 507.319586
Found 427 metabolites which its exact mass value is equals to given mass value 507.319586
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Eldelin
C27H41NO8 (507.28320260000004)
Deltaline is a diterpene alkaloid, a tertiary alcohol, a tertiary amino compound, an acetate ester, a cyclic acetal and an organic polycyclic compound. It derives from a hydride of an aconitane. Deltaline is a natural product found in Delphinium cheilanthum, Delphinium andersonii, and other organisms with data available. Deltaline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=6836-11-9 (retrieved 2024-07-09) (CAS RN: 6836-11-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Deltaline is a diterpenoid alkaloid and isolated from plants of the genus Delphinium delavayi Franch. Deltaline itself has analgesic properties, and plants of the genus Delphinium delavayi Franch have also been therapeutically used to treat rheumaticpain, paralysis due to stroke, rheumatoid arthritis[1]. Deltaline is a diterpenoid alkaloid and isolated from plants of the genus Delphinium delavayi Franch. Deltaline itself has analgesic properties, and plants of the genus Delphinium delavayi Franch have also been therapeutically used to treat rheumaticpain, paralysis due to stroke, rheumatoid arthritis[1].
Gymnodimine
C32H45NO4 (507.33484100000004)
Gymnodimine is found in mollusks. Gymnodimine is isolated from New Zealand oysters (Tiostrea chilensis) and the dinoflagellate Gymnodinium cf. mikimotoi. Isolated from New Zealand oysters (Tiostrea chilensis) and the dinoflagellate Gymnodinium cf. mikimotoi. Gymnodimine is found in mollusks.
LysoPE(0:0/20:1(11Z))
C25H50NO7P (507.33247200000005)
LysoPE(0:0/20:1(11Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/20:1(11Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(20:1(11Z)/0:0)
C25H50NO7P (507.33247200000005)
LysoPE(20:1(11Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(20:1(11Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPC(P-18:0/0:0)
C26H54NO6P (507.36885540000003)
LysoPC(P-18:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(P-18:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. LysoPC(P-18:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(P-18:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
Cholylvaline
C29H49NO6 (507.35596940000005)
Cholylvaline belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylvaline consists of the bile acid cholic acid conjugated to the amino acid Valine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylvaline, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylvaline appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
Chenodeoxycholylaspartic acid
Chenodeoxycholylaspartic acid belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholylaspartic acid consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Aspartic acid conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholylaspartic acid, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholylaspartic acid appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
(1S,10S,21R)-7-Ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
Deltaline
C27H41NO8 (507.28320260000004)
Lefamulin
C28H45NO5S (507.30182800000006)
Broussonetine A
C24H45NO10 (507.30433100000005)
Broussonetine A is a natural product found in Broussonetia kazinoki with data available.
(2E,6E,12E)-18-(2,6-Dioxo-4-piperidinyl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxo-2,6,12-octadecatrienoic acid
C27H41NO8 (507.28320260000004)
Phosphatidylethanolamine lyso 20:1
C25H50NO7P (507.33247200000005)
(2E,6E,11E)-18-(2,6-dioxopiperidin-4-yl)-9,13-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,11-trienoic acid
C27H41NO8 (507.28320260000004)
ACE inhibitor peptide C 107|Ala-Leu-Pro-His-Ala|ALPHA
Phe Val Ser Arg
Bonvalotidine A
C27H41NO8 (507.28320260000004)
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid
C27H41NO8 (507.28320260000004)
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid
C27H41NO8 (507.28320260000004)
Deltaline
C27H41NO8 (507.28320260000004)
Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Delphinium alkaloid Deltaline is a diterpenoid alkaloid and isolated from plants of the genus Delphinium delavayi Franch. Deltaline itself has analgesic properties, and plants of the genus Delphinium delavayi Franch have also been therapeutically used to treat rheumaticpain, paralysis due to stroke, rheumatoid arthritis[1]. Deltaline is a diterpenoid alkaloid and isolated from plants of the genus Delphinium delavayi Franch. Deltaline itself has analgesic properties, and plants of the genus Delphinium delavayi Franch have also been therapeutically used to treat rheumaticpain, paralysis due to stroke, rheumatoid arthritis[1].
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid_major
C27H41NO8 (507.28320260000004)
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid_minor
C27H41NO8 (507.28320260000004)
(2E,6E,12E)-18-(2,6-dioxopiperidin-4-yl)-9,11-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid_30.3\\%
C27H41NO8 (507.28320260000004)
((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)valine
C29H49NO6 (507.35596940000005)
Ala Arg Val Tyr
Ala Arg Tyr Val
Ala Val Arg Tyr
Ala Val Tyr Arg
Ala Tyr Arg Val
Ala Tyr Val Arg
Phe Ile Lys Thr
C25H41N5O6 (507.30566860000005)
Phe Ile Thr Lys
C25H41N5O6 (507.30566860000005)
Phe Lys Ile Thr
C25H41N5O6 (507.30566860000005)
Phe Lys Leu Thr
C25H41N5O6 (507.30566860000005)
Phe Lys Thr Ile
C25H41N5O6 (507.30566860000005)
Phe Lys Thr Leu
C25H41N5O6 (507.30566860000005)
Phe Leu Lys Thr
C25H41N5O6 (507.30566860000005)
Phe Leu Thr Lys
C25H41N5O6 (507.30566860000005)
Phe Arg Ser Val
Phe Arg Val Ser
Phe Ser Arg Val
Phe Ser Val Arg
Phe Thr Ile Lys
C25H41N5O6 (507.30566860000005)
Phe Thr Lys Ile
C25H41N5O6 (507.30566860000005)
Phe Thr Lys Leu
C25H41N5O6 (507.30566860000005)
Phe Thr Leu Lys
C25H41N5O6 (507.30566860000005)
Phe Val Arg Ser
Gly Ile Arg Tyr
Gly Ile Tyr Arg
Gly Leu Arg Tyr
Gly Leu Tyr Arg
Gly Arg Ile Tyr
Gly Arg Leu Tyr
Gly Arg Tyr Ile
Gly Arg Tyr Leu
Gly Tyr Ile Arg
Gly Tyr Leu Arg
Gly Tyr Arg Ile
Gly Tyr Arg Leu
His Pro Arg Val
His Pro Val Arg
His Arg Pro Val
His Arg Val Pro
His Val Pro Arg
His Val Arg Pro
Ile Phe Lys Thr
C25H41N5O6 (507.30566860000005)
Ile Phe Thr Lys
C25H41N5O6 (507.30566860000005)
Ile Gly Arg Tyr
Ile Gly Tyr Arg
Ile Lys Phe Thr
C25H41N5O6 (507.30566860000005)
Ile Lys Thr Phe
C25H41N5O6 (507.30566860000005)
Ile Arg Gly Tyr
Ile Arg Tyr Gly
Ile Thr Phe Lys
C25H41N5O6 (507.30566860000005)
Ile Thr Lys Phe
C25H41N5O6 (507.30566860000005)
Ile Tyr Gly Arg
Ile Tyr Arg Gly
Lys Phe Ile Thr
C25H41N5O6 (507.30566860000005)
Lys Phe Leu Thr
C25H41N5O6 (507.30566860000005)
Lys Phe Thr Ile
C25H41N5O6 (507.30566860000005)
Lys Phe Thr Leu
C25H41N5O6 (507.30566860000005)
Lys Ile Phe Thr
C25H41N5O6 (507.30566860000005)
Lys Ile Thr Phe
C25H41N5O6 (507.30566860000005)
Lys Leu Phe Thr
C25H41N5O6 (507.30566860000005)
Lys Leu Thr Phe
C25H41N5O6 (507.30566860000005)
Lys Thr Phe Ile
C25H41N5O6 (507.30566860000005)
Lys Thr Phe Leu
C25H41N5O6 (507.30566860000005)
Lys Thr Ile Phe
C25H41N5O6 (507.30566860000005)
Lys Thr Leu Phe
C25H41N5O6 (507.30566860000005)
Lys Val Val Tyr
C25H41N5O6 (507.30566860000005)
Lys Val Tyr Val
C25H41N5O6 (507.30566860000005)
Lys Tyr Val Val
C25H41N5O6 (507.30566860000005)
Leu Phe Lys Thr
C25H41N5O6 (507.30566860000005)
Leu Phe Thr Lys
C25H41N5O6 (507.30566860000005)
Leu Gly Arg Tyr
Leu Gly Tyr Arg
Leu Lys Phe Thr
C25H41N5O6 (507.30566860000005)
Leu Lys Thr Phe
C25H41N5O6 (507.30566860000005)
Leu Arg Gly Tyr
Leu Arg Tyr Gly
Leu Thr Phe Lys
C25H41N5O6 (507.30566860000005)
Leu Thr Lys Phe
C25H41N5O6 (507.30566860000005)
Leu Tyr Gly Arg
Leu Tyr Arg Gly
Pro His Arg Val
Pro His Val Arg
Pro Arg His Val
Pro Arg Val His
Pro Val His Arg
Pro Val Arg His
Arg Ala Val Tyr
Arg Ala Tyr Val
Arg Phe Ser Val
Arg Phe Val Ser
Arg Gly Ile Tyr
Arg Gly Leu Tyr
Arg Gly Tyr Ile
Arg Gly Tyr Leu
Arg His Pro Val
Arg His Val Pro
Arg Ile Gly Tyr
Arg Ile Tyr Gly
Arg Leu Gly Tyr
Arg Leu Tyr Gly
Arg Pro His Val
Arg Pro Val His
Arg Ser Phe Val
Arg Ser Val Phe
Arg Val Ala Tyr
Arg Val Phe Ser
Arg Val His Pro
Arg Val Pro His
Arg Val Ser Phe
Arg Val Tyr Ala
Arg Tyr Ala Val
Arg Tyr Gly Ile
Arg Tyr Gly Leu
Arg Tyr Ile Gly
Arg Tyr Leu Gly
Arg Tyr Val Ala
Ser Phe Arg Val
Ser Phe Val Arg
Ser Arg Phe Val
Ser Arg Val Phe
Ser Val Phe Arg
Ser Val Arg Phe
Thr Phe Ile Lys
C25H41N5O6 (507.30566860000005)
Thr Phe Lys Ile
C25H41N5O6 (507.30566860000005)
Thr Phe Lys Leu
C25H41N5O6 (507.30566860000005)
Thr Phe Leu Lys
C25H41N5O6 (507.30566860000005)
Thr Ile Phe Lys
C25H41N5O6 (507.30566860000005)
Thr Ile Lys Phe
C25H41N5O6 (507.30566860000005)
Thr Lys Phe Ile
C25H41N5O6 (507.30566860000005)
Thr Lys Phe Leu
C25H41N5O6 (507.30566860000005)
Thr Lys Ile Phe
C25H41N5O6 (507.30566860000005)
Thr Lys Leu Phe
C25H41N5O6 (507.30566860000005)
Thr Leu Phe Lys
C25H41N5O6 (507.30566860000005)
Thr Leu Lys Phe
C25H41N5O6 (507.30566860000005)
Val Ala Arg Tyr
Val Ala Tyr Arg
Val Phe Arg Ser
Val Phe Ser Arg
Val His Pro Arg
Val His Arg Pro
Val Lys Val Tyr
C25H41N5O6 (507.30566860000005)
Val Lys Tyr Val
C25H41N5O6 (507.30566860000005)
Val Pro His Arg
Val Pro Arg His
Val Arg Ala Tyr
Val Arg Phe Ser
Val Arg His Pro
Val Arg Pro His
Val Arg Ser Phe
Val Arg Tyr Ala
Val Ser Phe Arg
Val Ser Arg Phe
Val Val Lys Tyr
C25H41N5O6 (507.30566860000005)
Val Val Tyr Lys
C25H41N5O6 (507.30566860000005)
Val Tyr Ala Arg
Val Tyr Lys Val
C25H41N5O6 (507.30566860000005)
Val Tyr Arg Ala
Val Tyr Val Lys
C25H41N5O6 (507.30566860000005)
Tyr Ala Arg Val
Tyr Ala Val Arg
Tyr Gly Ile Arg
Tyr Gly Leu Arg
Tyr Gly Arg Ile
Tyr Gly Arg Leu
Tyr Ile Gly Arg
Tyr Ile Arg Gly
Tyr Lys Val Val
C25H41N5O6 (507.30566860000005)
Tyr Leu Gly Arg
Tyr Leu Arg Gly
Tyr Arg Ala Val
Tyr Arg Gly Ile
Tyr Arg Gly Leu
Tyr Arg Ile Gly
Tyr Arg Leu Gly
Tyr Arg Val Ala
Tyr Val Ala Arg
Tyr Val Lys Val
C25H41N5O6 (507.30566860000005)
Tyr Val Arg Ala
Tyr Val Val Lys
C25H41N5O6 (507.30566860000005)
PC(O-18:1/0:0)[S]
C26H54NO6P (507.36885540000003)
PC(O-18:1/0:0)[U]
C26H54NO6P (507.36885540000003)
PC(O-18:1/0:0)
C26H54NO6P (507.36885540000003)
PC(P-18:0/0:0)
C26H54NO6P (507.36885540000003)
LysoPE(20:1/0:0)
C25H50NO7P (507.33247200000005)
NA 27:7;O7
C27H41NO8 (507.28320260000004)
GSK1070916
C30H33N7O (507.27464480000003)
Latanoprostene Bunod
C27H41NO8 (507.28320260000004)
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EE - Prostaglandin analogues C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
Lefamulin
C28H45NO5S (507.30182800000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
Elacytarabine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Elacytarabine (CP 4055) is a lipid-conjugated derivative of the nucleoside analog cytarabine. Elacytarabine (CP 4055) is an antineoplastic agent with cytotoxicity in solid tumors.
BC-3781 intravenous
C28H45NO5S (507.30182800000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
Xenleta
C28H45NO5S (507.30182800000006)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
[5-[[6-[5-(4,7-Dihydroxy-7-methyl-1,6-dioxaspiro[2.5]octan-5-yl)-3-methylpenta-2,4-dienyl]-2,5-dimethyloxan-3-yl]amino]-5-oxopent-3-en-2-yl] acetate
C27H41NO8 (507.28320260000004)
5-{19-Hydroxy-2,15,18,24-tetramethyl-25-oxa-7-azatetracyclo[20.2.1.0^{6,11}.0^{11,16}]pentacosa-2,6,14,17-tetraen-14-yl}-3-methyl-2,5-dihydrofuran-2-one
C32H45NO4 (507.33484100000004)
(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
3-cyclohexyl-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
2-[(1R,3R,4aS,9aR)-6-(cyclohexylcarbamoylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
3-cyclohexyl-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
2-[(1R,3S,4aR,9aS)-6-(cyclohexylcarbamoylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
2-[(1S,3S,4aR,9aS)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
4-[[[(2R,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2S,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
2-[(1S,3S,4aS,9aR)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
2-[(1R,3S,4aS,9aR)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
4-[[[(2S,3R)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2R,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2S,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2R,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2R,3R)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
4-[[[(2S,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
C29H37N3O5 (507.27330720000003)
3-cyclohexyl-1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
3-cyclohexyl-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
3-cyclohexyl-1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
ethyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
2-[(1R,3R,4aR,9aS)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
2-[(1S,3R,4aS,9aR)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
2-[(1S,3R,4aR,9aS)-6-[[(cyclohexylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
ethyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
C29H37N3O5 (507.27330720000003)
3-cyclohexyl-1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
3-cyclohexyl-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
C30H41N3O4 (507.30969060000007)
1-(1E-octadecenyl)-sn-glycero-3-phosphocholine
C26H54NO6P (507.36885540000003)
(3E)-3-[[4-(Dimethylamino)phenyl]methylidene]-2-morpholin-4-yl-N-(3,4,5-trimethoxyphenyl)cyclohexene-1-carboxamide
C29H37N3O5 (507.27330720000003)
[2-hydroxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C26H54NO6P (507.36885540000003)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-icos-11-enoate
C25H50NO7P (507.33247200000005)
2-aminoethyl [3-[(Z)-henicos-11-enoxy]-2-hydroxypropyl] hydrogen phosphate
C26H54NO6P (507.36885540000003)
[3-[(Z)-heptadec-9-enoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C25H50NO7P (507.33247200000005)
[2-butanoyloxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] heptanoate
C25H50NO7P (507.33247200000005)
3-Hydroxy-2-(2-hydroxypentadecanoylamino)undecane-1-sulfonic acid
C26H53NO6S (507.35933980000004)
3-Hydroxy-2-(2-hydroxytridecanoylamino)tridecane-1-sulfonic acid
C26H53NO6S (507.35933980000004)
3-Hydroxy-2-(2-hydroxytetradecanoylamino)dodecane-1-sulfonic acid
C26H53NO6S (507.35933980000004)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] pentanoate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] propanoate
C25H50NO7P (507.33247200000005)
3-Hydroxy-2-(2-hydroxyhexadecanoylamino)decane-1-sulfonic acid
C26H53NO6S (507.35933980000004)
3-Hydroxy-2-(2-hydroxydodecanoylamino)tetradecane-1-sulfonic acid
C26H53NO6S (507.35933980000004)
[2-acetyloxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C25H50NO7P (507.33247200000005)
(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]dec-4-ene-1-sulfonic acid
C28H45NO5S (507.30182800000006)
(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxydodeca-4,8-diene-1-sulfonic acid
C28H45NO5S (507.30182800000006)
[2-propanoyloxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C25H50NO7P (507.33247200000005)
4-[3-acetyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
N-(decanoyl)-hexadecasphinganine-1-phosphate
C26H54NO6P (507.36885540000003)
N-(dodecanoyl)-tetradecasphinganine-1-phosphate
C26H54NO6P (507.36885540000003)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] butanoate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] hexanoate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] acetate
C25H50NO7P (507.33247200000005)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (Z)-pentadec-9-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-hexadec-9-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-heptadec-9-enoate
[3-propanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-tridec-9-enoate
[3-acetyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
LysoPC(17:1/0:0)
2-[[(E)-2-acetamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (E)-icos-11-enoate
C25H50NO7P (507.33247200000005)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (E)-icos-13-enoate
C25H50NO7P (507.33247200000005)
2-[hydroxy-[(E)-3-hydroxy-2-(octanoylamino)dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(dodecanoylamino)-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(propanoylamino)heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(decanoylamino)-3-hydroxydec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(nonanoylamino)undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(butanoylamino)-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(heptanoylamino)-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(undecanoylamino)non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(hexanoylamino)-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
1-(1Z-octadecenyl)-sn-glycero-3-phosphocholine
C26H54NO6P (507.36885540000003)
1-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine
C25H50NO7P (507.33247200000005)
FR901464
C27H41NO8 (507.28320260000004)
A spiro-epoxide with potent anticancer activity that lowers the mRNA levels of oncogenes and tumour supressor genes. It is isolated from Pseudomonas sp. no.2663.
1-[(11Z)-octadecenyl]-sn-glycero-3-phosphocholine
C26H54NO6P (507.36885540000003)
A 1-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as (11Z)-octadecenyl.
1-oleyl-sn-glycero-3-phosphocholine
C26H54NO6P (507.36885540000003)
A 1-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as oleyl (9Z-octadecenyl).
1-(10Z-heptadecenoyl)-sn-glycero-3-phosphocholine
C25H50NO7P (507.33247200000005)
A 1-O-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group is (10Z)-heptadecenoyl.
1-(9Z-heptadecenoyl)-glycero-3-phosphocholine
C25H50NO7P (507.33247200000005)
lysophosphatidylcholine O-18:1
C26H54NO6P (507.36885540000003)
A monoalkylglycerophosphocholine in which the alkyl group contains 18 carbons and one double bond. If R1 is an alkenyl group and R2 is a hydrogen then the molecule is a 1-alkenyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is an alkenyl group then the molecule is a 2-alkenyl-sn-glycero-3-phosphocholine.
lysophosphatidylcholine 17:1
C25H50NO7P (507.33247200000005)
A lysophosphatidylcholine in which the remaining acyl group contains 17 carbons and 1 double bond. If R1 is acyl and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is acyl then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
lysophosphatidylcholine O-18:1/0:0
C26H54NO6P (507.36885540000003)
A lysophosphatidylcholine O-18:1 in which the alkyl group is located at position 1.
lysophosphatidylethanolamine 20:1
C25H50NO7P (507.33247200000005)
A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 20 carbons and 1 double bond.
PC(16:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(15:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(19:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LdMePE(18:1)
C25H50NO7P (507.33247200000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(16:1)
C25H50NO7P (507.33247200000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMePE(18:1)
C25H50NO7P (507.33247200000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
NA-DOPA 22:6(4Z,7Z,10Z,13Z,16Z,19Z)
C31H41NO5 (507.29845760000006)
(2e,6e,12e)-9,11-dihydroxy-18-(2-hydroxy-6-oxo-4,5-dihydro-3h-pyridin-4-yl)-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid
C27H41NO8 (507.28320260000004)
(2-{[(2r)-2-hydroxy-3-[(4z)-octadec-4-en-1-yloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
C26H54NO6P (507.36885540000003)
1-hydroxy-13-[4-hydroxy-5-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyrrolidin-2-yl]tridecan-4-one
C24H45NO10 (507.30433100000005)
(2e,6e,8s,9s,10r,11r,12e,14s)-9,11-dihydroxy-18-(2-hydroxy-6-oxo-4,5-dihydro-3h-pyridin-4-yl)-8-methoxy-10,12,14-trimethyl-15-oxooctadeca-2,6,12-trienoic acid
C27H41NO8 (507.28320260000004)
n-[(2s,3r,4r,5s,6r)-2-{[(1s,2s,4ar,4bs,7s,10ar)-7-ethenyl-2-hydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
(1r,2s,3s,4s,5r,6s,8r,12r,13s,16r,19s,20r,21s)-14-ethyl-2-hydroxy-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-21-yl acetate
C27H41NO8 (507.28320260000004)
4-(acetyloxy)-11-ethyl-6,16-dihydroxy-18-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate
C27H41NO8 (507.28320260000004)
(2e,4s)-4-(acetyloxy)-n-[(2r,5s,6s)-6-[(2e,4e)-5-[(4r,5r,7s)-4,7-dihydroxy-7-methyl-1,6-dioxaspiro[2.5]octan-5-yl]-3-methylpenta-2,4-dien-1-yl]-2,5-dimethyloxan-3-yl]pent-2-enimidic acid
C27H41NO8 (507.28320260000004)
(2-{[(2r)-2-hydroxy-3-(octadec-11-en-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
C26H54NO6P (507.36885540000003)